ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 85 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $387,000 | -27.0% | 379,837 | -1.1% | 0.04% | -35.0% |
| Q2 2021 | $530,000 | +67.7% | 384,201 | +106.4% | 0.06% | +15.4% |
| Q1 2021 | $316,000 | +24.9% | 186,161 | -8.7% | 0.05% | +26.8% |
| Q4 2020 | $253,000 | +12.4% | 203,830 | +28.9% | 0.04% | +7.9% |
| Q3 2020 | $225,000 | +675.9% | 158,174 | +570.6% | 0.04% | +137.5% |
| Q2 2020 | $29,000 | -78.5% | 23,586 | -79.4% | 0.02% | -52.9% |
| Q1 2020 | $135,000 | -44.0% | 114,437 | 0.0% | 0.03% | +21.4% |
| Q4 2019 | $241,000 | -47.9% | 114,437 | -4.8% | 0.03% | +7.7% |
| Q3 2018 | $463,000 | +155.8% | 120,158 | +123.9% | 0.03% | +188.9% |
| Q2 2018 | $181,000 | +60.2% | 53,658 | 0.0% | 0.01% | +50.0% |
| Q1 2018 | $113,000 | -41.1% | 53,658 | +215.6% | 0.01% | -60.0% |
| Q4 2013 | $192,000 | -42.7% | 17,000 | -45.3% | 0.02% | -42.3% |
| Q3 2013 | $335,000 | – | 31,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 1,652,190 | $3,817,000 | 2.58% |
| LINCOLN CAPITAL CORP | 62,000 | $143,000 | 0.13% |
| Laurion Capital Management LP | 1,944,727 | $4,492,000 | 0.08% |
| Cedar Wealth Management, LLC | 46,395 | $107,000 | 0.08% |
| Fosun International Ltd | 301,708 | $709,000 | 0.04% |
| BCWM, LLC | 35,100 | $811,000 | 0.04% |
| Engineers Gate Manager LP | 170,800 | $395,000 | 0.03% |
| Alpine Global Management, LLC | 45,211 | $104,000 | 0.03% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $578,000 | 0.02% |
| SECTORAL ASSET MANAGEMENT INC | 73,778 | $170,000 | 0.02% |